Patent ID: 7345073

Claim:
A method for the treatment of a male individual suffering from cryptorchidism comprising administering to the individual a therapeutically effective amount of an aromatase inhibitor, wherein the aromatase inhibitor is a compound of selected from the group consisting of anastrozole, fadrozole, letrozole, vorozole, roglethimide, atamestane, exemestane, formestane, YM-511 (4-[-(4-bromobenzyl)-N-(4-cyanophenyl)amino]-4H-1,2,4-triazole), ZD-1033 (anastrozole) and NKS-01 (14-α-hydroxyandrost-4-ene-3,6,17-trione); or a compound of formula (I) wherein R 1 is hydrogen, methyl, methoxy, nitro, amino, cyano, trifluoromethyl, difluoromethyl, monofluoromethyl or halogen; R 2 is a heterocyclic radical selected from 1-imidazolyl, triazolyl, tetrazolyl, pyrazolyl, pyrimidinyl, oxazolyl, thiazolyl, isoxazolyl and isothiazolyl; R 3 is hydrogen or hydroxy; R 4 is hydrogen; R 5 is hydrogen or hydroxy, or R 3 and R 5 taken together are a bond, or R 4 and R 5 taken together are ═O when R 3 is hydrogen; R 6 is methylene, ethylene, —CHOH—, —CH 2 CHOH—, —CHOH—CH 2 —, —CH═CH— or —C(═O)—, or R 5 and R 6 taken together are ═CH— or ═CH—CH 2 —; or a stereoisomer, or a non-toxic pharmaceutically acceptable acid addition salt thereof, or a mixture thereof.